TrialLancet (London, England)2023

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.

Jesse J Swen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.